Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Dunn

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
AIDS Patient Care and Stds|October 30, 2009
Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult servicesCaroline Foster, Ali Judd, Pat Tookey, et al.
Neurology|February 25, 2018
Attention-deficit/hyperactivity disorder medication and seizuresKelsey K Wiggs, Zheng Chang, Patrick D Quinn, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 22, 2005
A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHDMargaret Weiss, Rosemary Tannock, Christopher Kratochvil, et al.
AIDS Research and Human Retroviruses|July 9, 2019
HIV-1 Transmission Patterns in Men Who Have Sex with Men: Insights from Genetic Source Attribution AnalysisStéphane Le Vu, Oliver Ratmann, Valerie Delpech, et al.
AIDS (London, England)|February 9, 2010
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control studyAli Judd, Katherine L Boyd, Wolfgang Stöhr, et al.
Developmental Medicine and Child Neurology|June 27, 2007
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetineJoachim F Wernicke, Karen Chilcott Holdridge, Ling Jin, et al.
Antiviral Therapy|February 4, 2012
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UKKatherine L Donegan, A Sarah Walker, David Dunn, et al.
AIDS (London, England)|June 10, 2014
HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivityNiamh M Keane, Rebecca K Pavlos, Elizabeth McKinnon, et al.
AIDS (London, England)|February 8, 2011
The impact of HIV drug resistance testing on changes to treatmentLoveleen Bansi, Colette Smith, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2010
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART)Loveleen Bansi, Anna Maria Geretti, David Dunn, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
AIDS Patient Care and Stds|October 30, 2009
Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult servicesCaroline Foster, Ali Judd, Pat Tookey, et al.
Neurology|February 25, 2018
Attention-deficit/hyperactivity disorder medication and seizuresKelsey K Wiggs, Zheng Chang, Patrick D Quinn, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|June 22, 2005
A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHDMargaret Weiss, Rosemary Tannock, Christopher Kratochvil, et al.
AIDS Research and Human Retroviruses|July 9, 2019
HIV-1 Transmission Patterns in Men Who Have Sex with Men: Insights from Genetic Source Attribution AnalysisStéphane Le Vu, Oliver Ratmann, Valerie Delpech, et al.
AIDS (London, England)|February 9, 2010
Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control studyAli Judd, Katherine L Boyd, Wolfgang Stöhr, et al.
Developmental Medicine and Child Neurology|June 27, 2007
Seizure risk in patients with attention-deficit-hyperactivity disorder treated with atomoxetineJoachim F Wernicke, Karen Chilcott Holdridge, Ling Jin, et al.
Antiviral Therapy|February 4, 2012
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UKKatherine L Donegan, A Sarah Walker, David Dunn, et al.
AIDS (London, England)|June 10, 2014
HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivityNiamh M Keane, Rebecca K Pavlos, Elizabeth McKinnon, et al.
AIDS (London, England)|February 8, 2011
The impact of HIV drug resistance testing on changes to treatmentLoveleen Bansi, Colette Smith, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2010
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART)Loveleen Bansi, Anna Maria Geretti, David Dunn, et al.
Pageof 15